BYL719 Alpelisib
To Order Contact us: lieven@wlsolutions.be
Alpelisib |
||
GW0189-10 | 10 | EUR 401.4 |
Alpelisib |
||
GW0189-5 | 5 | EUR 287 |
Alpelisib |
||
T1921-10mg | 10mg | Ask for price |
Description: Alpelisib |
Alpelisib |
||
T1921-1g | 1g | Ask for price |
Description: Alpelisib |
Alpelisib |
||
T1921-1mg | 1mg | Ask for price |
Description: Alpelisib |
Alpelisib |
||
T1921-50mg | 50mg | Ask for price |
Description: Alpelisib |
Alpelisib |
||
T1921-5mg | 5mg | Ask for price |
Description: Alpelisib |
Alpelisib hydrochloride |
||
T14191-10mg | 10mg | Ask for price |
Description: Alpelisib hydrochloride |
Alpelisib hydrochloride |
||
T14191-1g | 1g | Ask for price |
Description: Alpelisib hydrochloride |
Alpelisib hydrochloride |
||
T14191-1mg | 1mg | Ask for price |
Description: Alpelisib hydrochloride |
Alpelisib hydrochloride |
||
T14191-50mg | 50mg | Ask for price |
Description: Alpelisib hydrochloride |
Alpelisib hydrochloride |
||
T14191-5mg | 5mg | Ask for price |
Description: Alpelisib hydrochloride |
Alpelisib, Free Base [CAS# 1217486-61-7 ] |
||
A-4477 | 5 mg | EUR 59 |
BYL-719 |
||
A8346-100 | 100 mg | EUR 1039.2 |
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
BYL-719 |
||
A8346-20 | 20 mg | EUR 338.4 |
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
BYL-719 |
||
A8346-5 | 5 mg | EUR 184.8 |
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
BYL-719 |
||
A8346-5.1 | 10 mM (in 1mL DMSO) | EUR 199.2 |
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
BYL-719 |
||
A8346-S | Evaluation Sample | EUR 97.2 |
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers. |
Alpertine |
||
HY-U00243 | 1mg | EUR 2373.6 |
Alpertine |
||
T10290-10mg | 10mg | Ask for price |
Description: Alpertine |
Alpertine |
||
T10290-1g | 1g | Ask for price |
Description: Alpertine |
Alpertine |
||
T10290-1mg | 1mg | Ask for price |
Description: Alpertine |
Alpertine |
||
T10290-50mg | 50mg | Ask for price |
Description: Alpertine |
Alpertine |
||
T10290-5mg | 5mg | Ask for price |
Description: Alpertine |
ALP-B/ Rat ALP- B ELISA Kit |
||
ELA-E0473r | 96 Tests | EUR 1063.2 |
Rat ALP ELISA Kit |
||
ERA0038 | 96Tests | EUR 625.2 |
Goat ALP ELISA Kit |
||
EGTA0038 | 96Tests | EUR 625.2 |
Mouse ALP ELISA Kit |
||
EMA0038 | 96Tests | EUR 625.2 |
Sheep ALP ELISA Kit |
||
ESA0038 | 96Tests | EUR 625.2 |
ALP ELISA KIT|Human |
||
EF009206 | 96 Tests | EUR 826.8 |